- Home
- GMED vs RVTY Comparison
GMED vs RVTY Comparison
Compare GMED & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GMED | RVTY |
|---|---|---|
| Founded | 2003 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 11.7B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | GMED | RVTY |
|---|---|---|
| Price | $93.99 | $116.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 14 |
| Target Price | $95.92 | ★ $113.46 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 02-24-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | ★ 358.86 | N/A |
| EPS | ★ 3.08 | 1.99 |
| Revenue | $2,769,804,000.00 | ★ $2,813,367,000.00 |
| Revenue This Year | $17.65 | $5.30 |
| Revenue Next Year | $8.37 | $3.03 |
| P/E Ratio | ★ $30.18 | $56.18 |
| Revenue Growth | ★ 11.75 | 3.37 |
| 52 Week Low | $51.79 | $81.36 |
| 52 Week High | $101.40 | $128.29 |
Technical Indicators
Market Signals| Indicator | GMED | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 60.13 | 71.55 |
| Support Level | $91.10 | $110.17 |
| Resistance Level | $94.69 | $115.78 |
| Average True Range (ATR) | 3.21 | 4.09 |
| MACD | -0.03 | 1.37 |
| Stochastic Oscillator | 52.96 | 100.00 |
Price Performance
Historical ComparisonAbout GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.